Jianxun Qi
jxqi@im.ac.cn
Chinese, English
Beijing
University of Chinese Academy of Sciences
Medical School
  • 2004-09 to 2008-07 PhD: Institute of Physics, Chinese Academy of Sciences
  • 2016-08 to Present - Institute of Microbiology, Chinese Academy of Sciences - Researcher
  • 2011-08 to 2016-06 - Institute of Microbiology, Chinese Academy of Sciences - Associate Researcher
  • 2008-07 to 2011-08 - Institute of Microbiology, Chinese Academy of Sciences - Assistant Researcher
  • Clarivate Highly Cited Researcher (2023): Other
  • World's Top 2% Scientists (2023): Other
  • Clarivate Highly Cited Researcher (2022): Other
  • Clarivate Highly Cited Researcher (2021): Other
  • Chinese Preventive Medicine Association Science and Technology Award (2017): First Prize, Ministerial Level
  • Beijing Science and Technology Award (2011): First Prize, Provincial Level
Molecular mechanisms of pathogenic microorganisms invading host cells
Design of vaccines based on dominant epitopes
Design of inhibitors
  • A Wider and Deeper Peptide-Binding Groove for the Class I Molecules from B15 Compared with B19 Chickens Correlates with Relative Resistance to Marek's Disease, JOURNAL OF IMMUNOLOGY, 2023
  • Cryo-EM structure of severe fever with thrombocytopenia syndrome virus, NATURE COMMUNICATIONS, 2023
  • Near-atomic architecture of Singapore grouper iridovirus and implications for giant virus assembly, NATURE COMMUNICATIONS, 2023
  • In Silico Discovery of Small Molecule Modulators Targeting the Achilles' Heel of SARS-CoV-2 Spike Protein, ACS CENTRAL SCIENCE, 2023
  • Mechanistic insights into DNA binding and cleavage by a compact type I-F CRISPR-Cas system in bacteriophage, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2023
  • Structure of monkeypox virus DNA polymerase holoenzyme, SCIENCE, 2023
  • The mechanism of STING autoinhibition and activation, MOLECULAR CELL, 2023
  • Characterization of the high-affinity anti-CTLA-4 monoclonal antibody JS007 for immune checkpoint therapy of cancer, MABS, 2023
  • An updated atlas of antibody evasion by SARS-CoV-2 Omicron sub-variants including BQ.1.1 and XBB, CELL REPORTS MEDICINE, 2023
  • Host range and structural analysis of bat-origin RshSTT182/200 coronavirus binding to human ACE2 and its animal orthologs, EMBO JOURNAL, 2023
  • Molecular mechanism of de novo replication by the Ebola virus polymerase, Nature, 2023
  • Protective prototype-Beta and Delta-Omicron chimeric RBD-dimer vaccines against SARS-CoV-2, CELL, 2022
  • VarEPS: an evaluation and prewarning system of known and virtual variations of SARS-CoV-2 genomes, NUCLEIC ACIDS RESEARCH, 2022
  • Structural and inhibitor sensitivity analysis of influenza B-like viral neuraminidases derived from Asiatic toad and spiny eel, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2022
  • Molecular basis of differential receptor usage for naturally occurring CD55-binding and -nonbinding coxsackievirus B3 strains, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2022
  • Structural basis of human ACE2 higher binding affinity to currently circulating Omicron SARS-CoV-2 sub-variants BA.2 and BA.1.1, CELL, 2022
  • Molecular Basis of Mink ACE2 Binding to SARS-CoV-2 and Its Mink-Derived Variants, JOURNAL OF VIROLOGY, 2022
  • Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2, CELL, 2022
  • Atlas of currently available human neutralizing antibodies against SARS-CoV-2 and escape by Omicron sub-variants BA.1/BA.1.1/BA.2/BA.3, IMMUNITY, 2022
  • Cross-species recognition and molecular basis of SARS-CoV-2 and SARS-CoV binding to ACE2s of marine animals, NATIONAL SCIENCE REVIEW, 2022
  • Binding and structural basis of equine ACE2 to RBDs from SARS-CoV, SARS-CoV-2 and related coronaviruses, NATURE COMMUNICATIONS, 2022
  • Structure of the Ebola virus polymerase complex, NATURE, 2022
  • Omicron SARS-CoV-2 mutations stabilize spike up-RBD conformation and lead to a non-RBM-binding monoclonal antibody escape, NATURE COMMUNICATIONS, 2022
  • Structural basis for a human broadly neutralizing influenza A hemagglutinin stem-specific antibody including H17/18 subtypes, Nature Communications, 2022
  • Application of an Integrated Platform for Basic and Applied Research in the Prevention and Control of the COVID-19 Pandemic, 中国科学基金, 2022
  • Stability and Structure of Bat Major Histocompatibility Complex Class I with Heterologous beta 2-Microglobulin, JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2021
  • Structural Basis of SARS-CoV-2 Polymerase Inhibition by Favipiravir, 创新(英文), 2021
  • Molecular basis of cross-species ACE2 interactions with SARS-CoV-2-like viruses of pangolin origin, EMBO JOURNAL, 2021
  • The molecular basis for SARS-CoV-2 binding to dog ACE2, NATURE COMMUNICATIONS, 2021
  • Structural basis of malarial parasite RIFIN-mediated immune escape against LAIR1, CELL REPORTS, 2021
  • Structure-based design of 5 '-substituted 1,2,3-triazolylated oseltamivir derivatives as potent influenza neuraminidase inhibitors, RSC ADVANCES, 2021
  • Atypical TNF-TNFR superfamily binding interface in the GITR-GITRL complex for T cell activation, CELL REPORTS, 2021
  • 新型冠状病毒结合穿山甲ACE2受体的分子机制, 科学通报, 2021
  • Cross-species recognition of SARS-CoV-2 to bat ACE2, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2021
  • Human group A rotavirus P25 VP8* specifically binds to A-type histo-blood group antigen, VIROLOGY, 2021
  • Cell entry by SARS-CoV-2, TRENDS IN BIOCHEMICAL SCIENCES, 2021
  • Protective Zika vaccines engineered to eliminate enhancement of dengue infection via immunodominance switch, NATURE IMMUNOLOGY, 2021
  • Molecular insights into receptor binding of recent emerging SARS-CoV-2 variants, NATURE COMMUNICATIONS, 2021
  • Structural insights into the cis and trans assembly of human trophoblast cell surface antigen 2, ISCIENCE, 2021
  • Crystal structure of the African swine fever virus core shell protein p15, 生物安全与健康(英文), 2021
  • Binding and molecular basis of the bat coronavirus RaTG13 virus to ACE2 in humans and other species, CELL, 2021
  • A broadly protective antibody that targets the flavivirus NS1 protein, SCIENCE, 2021
  • Cryo-EM structures of Lassa and Machupo virus polymerases complexed with cognate regulatory Z proteins identify targets for antivirals, NATURE MICROBIOLOGY, 2021
  • Crystal structure of the African swine fever virus core shell protein p15, BIOSAFETY AND HEALTH, 2021
  • Structural basis for the inhibition of the SARS-CoV-2 main protease by the anti-HCV drug narlaprevir, SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2021
  • Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease, NATURE COMMUNICATIONS, 2020
  • Structural insight into arenavirus replication machinery, NATURE, 2020
  • Analysis of ACE2 Gene-Encoded Proteins Across Mammalian Species, FRONTIERS IN VETERINARY SCIENCE, 2020
  • Structures of the four Ig-like domain LILRB2 and the four-domain LILRB1 and HLA-G1 complex, CELLULAR &
Pathogenic Microorganisms Host Cells Molecular Mechanisms Vaccines Dominant Epitopes Inhibitors Nanoparticle Vaccine Antibodies Enzyme Inhibitors Pathogen Lifecycle

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.